Pulse Biosciences (PLSE) Long-Term Investments (2017)
Pulse Biosciences' (PLSE) quarterly Long-Term Investments came in at $4.6 million in Q4 2017.
Pulse Biosciences (PLSE) Long-Term Investments (2017) Analysis & Trends
Pulse Biosciences' Long-Term Investments history runs 1 years deep, the most recent figure standing at $4.6 million for Q4 2017.
- On a quarterly basis, Long-Term Investments changed N/A year-over-year to $4.6 million in Q4 2017; TTM through Dec 2017 was $4.6 million, a N/A change from a year earlier, with the FY2017 full-year figure at $4.6 million, changed N/A from the prior year.
- Long-Term Investments steadied at $4.6 million in Q4 2017 per PLSE's latest filing.
- Across five years, Long-Term Investments topped out at $4.6 million in Q4 2017 and bottomed at $4.6 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 800.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 207.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Pulse Biosciences | 2.09 Bn | 2.01 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 4.59 Mn |